Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.89B |
| 2 |
Apple
AAPL
|
+$1.71B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.18B |
| 4 |
Pfizer
PFE
|
+$1.15B |
| 5 |
Duke Energy
DUK
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.54B |
| 2 |
Medtronic
MDT
|
+$1.44B |
| 3 |
Eli Lilly
LLY
|
+$1.39B |
| 4 |
NextEra Energy
NEE
|
+$1.1B |
| 5 |
JPMorgan Chase
JPM
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.56% |
| 2 | Technology | 19.3% |
| 3 | Financials | 12.11% |
| 4 | Industrials | 10.24% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Eldorado Gold
EGO
$9.36B
| $17.5M | ﹤0.01% |
1,808,526
-575,473
| -24% | -$5M |
|
952
Evercore
EVR
$12.4B
| $17.4M | ﹤0.01% |
295,782
-96,235
| -25% | -$5.23M |
|
953
AES
AES
$10.5B
| $17.4M | ﹤0.01% |
1,198,098
-386,905
| -24% | -$5.08M |
|
|
LEVL
954
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $17.2M | ﹤0.01% |
1,026,165
+10,398
| +1% | +$181K |
|
|
CBIO
955
Crescent Biopharma
CBIO
$583M
| $17.1M | ﹤0.01% |
45,584
-2,735
| -6% | -$774K |
|
|
IBKC
956
DELISTED
IBERIABANK Corp
IBKC
| $17.1M | ﹤0.01% |
375,085
-760,681
| -67% | -$31.4M |
|
957
Texas Roadhouse
TXRH
$13.7B
| $16.9M | ﹤0.01% |
322,264
+155,351
| +93% | +$7.57M |
|
958
ePlus
PLUS
$2.46B
| $16.6M | ﹤0.01% |
468,796
+7,946
| +2% | +$271K |
|
959
Chefs' Warehouse
CHEF
$4.51B
| $16.6M | ﹤0.01% |
1,219,034
+306,581
| +34% | +$4.23M |
|
960
IAMGOLD
IAG
$9.18B
| $16.4M | ﹤0.01% |
4,154,434
+908,267
| +28% | +$3.12M |
|
961
Lumen
LUMN
$6.21B
| $16.4M | ﹤0.01% |
1,634,264
-24,827
| -1% | -$248K |
|
|
AERI
962
DELISTED
Aerie Pharmaceuticals
AERI
| $16.4M | ﹤0.01% |
1,109,758
-5,626,464
| -84% | -$83.2M |
|
963
MarineMax
HZO
$800M
| $16.3M | ﹤0.01% |
729,706
-211,330
| -22% | -$3.48M |
|
|
HDS
964
DELISTED
HD Supply Holdings, Inc.
HDS
| $16.2M | ﹤0.01% |
+467,109
| New | +$14.5M |
|
965
Henry Schein
HSIC
$10.2B
| $16.1M | ﹤0.01% |
276,350
+216,867
| +365% | +$12.1M |
|
966
Goldman Sachs
GS
$316B
| $16.1M | ﹤0.01% |
81,474
-19,624
| -19% | -$3.68M |
|
|
TECX
967
Tectonic Therapeutic
TECX
$557M
| $16M | ﹤0.01% |
76,472
+2,566
| +3% | +$529K |
|
968
Infosys
INFY
$50.3B
| $15.9M | ﹤0.01% |
1,649,460
-123,170
| -7% | -$1.1M |
|
969
Ovintiv
OVV
$16.3B
| $15.8M | ﹤0.01% |
1,669,581
-1,087,498
| -39% | -$7.58M |
|
970
Aptiv
APTV
$9.97B
| $15.8M | ﹤0.01% |
203,013
-60,462
| -23% | -$4.16M |
|
971
Interparfums
IPAR
$4.03B
| $15.8M | ﹤0.01% |
328,400
+13,836
| +4% | +$623K |
|
972
iShares MSCI ACWI ETF
ACWI
$33.4B
| $15.7M | ﹤0.01% |
212,694
-305,124
| -59% | -$21.3M |
|
|
ARD
973
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $15.6M | ﹤0.01% |
1,207,248
+31,717
| +3% | +$395K |
|
|
AKUS
974
DELISTED
Akouos Inc
AKUS
| $15.5M | ﹤0.01% |
+689,986
| New | +$15.4M |
|
975
iShares MSCI Canada ETF
EWC
$6.29B
| $15.5M | ﹤0.01% |
597,883
+453,447
| +314% | +$11.1M |
|
Similar funds
Wellington Management Group's Q2 2020 Portfolio in Review
As of Q2 2020, Wellington Management Group held 2,062 positions worth $449B, up 19% from $378B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q2 2020 filing shows 180 new, 666 increased, 896 reduced and 228 closed positions. Its largest new stake was DraftKings: 11,003,857 shares worth $355M. The largest sale was Walmart Inc, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2020 buy was DraftKings: 11,003,857 shares worth $355M.
- Wellington Management Group added most to Procter & Gamble in Q2 2020, an estimated $1.89B increase.
- Wellington Management Group's biggest Q2 2020 reduction was Walmart Inc, cutting an estimated $1.54B.
- Wellington Management Group fully exited Raytheon Company in Q2 2020, selling an estimated $774M.
- Wellington Management Group's ten largest holdings make up 18% of its $449B portfolio in Q2 2020.
- Wellington Management Group opened 180 new positions and closed 228 in Q2 2020.
- Wellington Management Group's portfolio value rose 19% quarter-over-quarter to $449B.
Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.